Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis (original) (raw)
Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis
Anil Tyagi
Medical Microbiology and Immunology, 2004
View PDFchevron_right
Cellular Immune Responses to Recombinant Mycobacterium bovis BCG Constructs Expressing Major Antigens of Region of Difference 1 of Mycobacterium tuberculosis
AbuSalim Mustafa
Clinical and Vaccine Immunology, 2013
View PDFchevron_right
Cloning of the Gene Encoding a 22-Kilodalton Cell Surface Antigen of Mycobacterium bovis BCG and Analysis of Its Potential for DNA Vaccination against Tuberculosis
Kris Huygen
Infection and Immunity, 2000
View PDFchevron_right
Novel vaccination strategies based on recombinant Mycobacterium bovis BCG
Guido Dietrich
International Journal of Medical Microbiology, 2003
View PDFchevron_right
Development of Escherichia coli and Mycobacterium smegmatis recombinants expressing major Mycobacterium tuberculosis-specific antigenic proteins
AbuSalim Mustafa
International Journal of Mycobacteriology, 2016
View PDFchevron_right
Recombinant Mycobacterium bovis BCG
Odir Dellagostin, Sibele Borsuk
Vaccine, 2009
View PDFchevron_right
The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis-Infected Guinea Pigs
Yves Lobet
Infection and Immunity, 2004
View PDFchevron_right
Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments
Guido Dietrich
Vaccine, 2003
View PDFchevron_right
Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis
N. Festjens
EMBO Molecular Medicine, 2011
View PDFchevron_right
A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
g harth
Infection and Immunity, 2008
View PDFchevron_right
Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis
Ahmad-Reza Jabbari
Jundishapur Journal of Microbiology, 2015
View PDFchevron_right
Enhancing the Protective Efficacy of Mycobacterium bovis BCG Vaccination against Tuberculosis by Boosting with the Mycobacterium tuberculosis Major Secretory Protein
g harth
Infection and Immunity, 2005
View PDFchevron_right
Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens from Mycobacterium tuberculosis
Kris Huygen
The Journal of Infectious Diseases, 2004
View PDFchevron_right
RECOMBINANT PROTEINS OF MYCOBACTERIUM TUBERCULOSIS – THE POTENTIAL SERODIAGNOSTIC CANDIDATES FROM DELETED REGIONS
TJPRC Publication
TJPRC, 2014
View PDFchevron_right
Generation of Attenuated Mycobacterium bovis Strains by Signature-Tagged Mutagenesis for Discovery of Novel Vaccine Candidates
Shalome Bassett
Infection and Immunity, 2005
View PDFchevron_right
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG
g harth
Vaccine, 2006
View PDFchevron_right
Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin
Ana Carolina Peiter
Memorias do Instituto Oswaldo Cruz, 2017
View PDFchevron_right
Cloning and sequencing of M. tb gene Rv0378 for making subunit based DNA vaccine
Nuzhat Sial, Mirza Imran Shahzad
View PDFchevron_right
Designing and Construction of a DNA Vaccine Encoding Tb10.4 Gene of Mycobacterium tuberculosis
Iranian Journal of Pathology, Zahra Meshkat
View PDFchevron_right
Cloning and characterization of Rv1980c gene encoding MPT64 Protein from Mycobacterium tuberculosis as a new candidate vaccine of tuberculosis
Rosana agus
Journal of Physics: Conference Series, 2019
View PDFchevron_right
Molecular Cloning and Immunologic Reactivity of a Novel Low Molecular Mass Antigen of Mycobacterium tuberculosis
Mark Alderson
The Journal of Immunology, 1998
View PDFchevron_right
Designing and Construction of a Cloning Vector Encoding mtb32C and mpt51 Fragments of Mycobacterium tuberculosis as a DNA Vaccine Candidate
Aida Gholoobi
Iranian Journal of Pathology, 2018
View PDFchevron_right
Construction of a modified vector for efficient purification of recombinant Mycobacterium tuberculosis proteins expressed in Escherichia coli
Maisa Mahmoud
View PDFchevron_right
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins
Elisa Binda
Microbial Cell Factories, 2013
View PDFchevron_right
Mycobacterial Gene Cloning and Expression, Comparative Genomics, Bioinformatics and Proteomics in Relation to the Development of New Vaccines and Diagnostic Reagents
AbuSalim Mustafa
Medical Principles and Practice, 2005
View PDFchevron_right
Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
g harth
Proceedings of the National Academy of Sciences, 2000
View PDFchevron_right
Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice
Vikas Srivastava
Vaccine, 2011
View PDFchevron_right
Enhanced Protection against Tuberculosis by Vaccination with RecombinantMycobacterium microtiVaccine That Induces T Cell Immunity against Region of Difference 1 Antigens
Laleh Majlessi
The Journal of Infectious Diseases, 2004
View PDFchevron_right
Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures
Bryce Buddle
Microbiology (Reading, England), 2002
View PDFchevron_right